Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice recommendations from the EBMT-Reference-Cited by-同舟云学术

Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice recommendations from the EBMT

Published:2024-06 Issue:6 Volume:11 Page:e448-e458
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Pagliuca Simona,Schmid Christoph,Santoro Nicole,Simonetta Federico,Battipaglia Giorgia,Guillaume Thierry,Greco Raffaella,Onida Francesco,Sánchez-Ortega Isabel,Yakoub-Agha Ibrahim,Kuball Jurgen,Hazenberg Mette D,Ruggeri Annalisa

Publisher

Elsevier BV

Reference74 articles.

1. Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years;Passweg;Bone Marrow Transplant,2021

2. Graft-versus-host disease versus graft-versus-leukaemia;Negrin;Hematology Am Soc Hematol Educ Program,2015

3. Long-term outcomes and risk factor analysis of steroid-refractory graft versus host disease after hematopoietic stem cell transplantation;Pagliuca;Bone Marrow Transplant,2021

4. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients;Kolb;Blood,1990

5. How I treat high-risk acute myeloid leukemia using preemptive adoptive cellular immunotherapy;Biederstädt;Blood,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urgent need: evidence-based use of donor lymphocyte infusions;The Lancet Haematology;2024-09

2. Hypomethylating Agents are Effective in Treatment for Relapsed Myelofibrosis After Allogeneic Hematopoietic Cell Transplantation;Transplantation and Cellular Therapy;2024-08